Log In
BCIQ
Print this Print this
 

Biosimilar etanercept

  Manage Alerts
Collapse Summary General Information
Company Biocon Ltd.
DescriptionBiosimilar of etanercept, a recombinant p75 tumor necrosis factor (TNF) receptor linked to the Fc portion of human IgG1 (TNFr:Fc)
Molecular Target Tumor necrosis factor (TNF) alpha ; Lymphotoxin alpha
Mechanism of ActionTumor necrosis factor (TNF) alpha inhibitor; Biosimilar
Therapeutic ModalityBiologic: Fusion protein
Latest Stage of DevelopmentPreclinical
Standard Indication Autoimmune (unspecified)
Indication DetailsTreat autoimmune diseases
Regulatory Designation
PartnerMylan N.V.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today